CARDIOTROPISCHE RADIOPHARMAZEUTIKA,DIE EINEN ÜBERGANGSMETALL-NITRID-KOMPLEX ENTHALTEN UND DIE EINE RASCHE MYOCARDIAL-ELIMINIERUNG AUFWEISEN

CARDIOTROPISCHE RADIOPHARMAZEUTIKA,DIE EINEN ÜBERGANGSMETALL-NITRID-KOMPLEX ENTHALTEN UND DIE EINE RASCHE MYOCARDIAL-ELIMINIERUNG AUFWEISEN

PCT No. PCT/FR96/01103 Sec. 371 Date Jan. 16, 1998 Sec. 102(e) Date Jan. 16, 1998 PCT Filed Jul. 16, 1996 PCT Pub. No. WO97/03705 PCT Pub. Date Feb. 6, 1997The present invention relates to cardiac tropism radiopharmaceutical products incorporating a nitride complex os a transition metal and having a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: BELLANDE, EMMANUEL, COMAZZI, VERONIQUE, LAINE, JACQUES, PASQUALINI, ROBERTO
Format: Patent
Sprache:ger
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator BELLANDE, EMMANUEL
COMAZZI, VERONIQUE
LAINE, JACQUES
PASQUALINI, ROBERTO
description PCT No. PCT/FR96/01103 Sec. 371 Date Jan. 16, 1998 Sec. 102(e) Date Jan. 16, 1998 PCT Filed Jul. 16, 1996 PCT Pub. No. WO97/03705 PCT Pub. Date Feb. 6, 1997The present invention relates to cardiac tropism radiopharmaceutical products incorporating a nitride complex os a transition metal and having a rapid myocardial clearance. These complexes are based on the formula:(M 3BOND N)L1L2 (I)in which M is a transition metal such as 99mTc and L1 and L2 comply with the formula: in which at least one of the R and R' represents a branched alkyl group having one or more ether functions, a tetrahydrofurfuryl or ether group, a tetrahydrofurfuryl or dioxaspiro or dialkoxy piperidino groups.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ATE216267TT1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ATE216267TT1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ATE216267TT13</originalsourceid><addsrcrecordid>eNqNjT0OgkAQhWksjHqHtZcCTLQeYYAJuwNZhvjTEGLWyigJHsMjeBsvJiHaW7285Hvfm3rPCGxMhdiipCrKUFkYapmBNXDCWiiHVUyokBhZvV87tClwWhkU0NpnEkuxnxem1HhQyJKBloGsOVa_3eAc1eZYjG-gfdRkiAltzamCOtkjVchzb3Jpr71bfHPmLROUKPNdd29c37Vnd3OPBgTDYBNutiLB-h_mA2TTQXk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>CARDIOTROPISCHE RADIOPHARMAZEUTIKA,DIE EINEN ÜBERGANGSMETALL-NITRID-KOMPLEX ENTHALTEN UND DIE EINE RASCHE MYOCARDIAL-ELIMINIERUNG AUFWEISEN</title><source>esp@cenet</source><creator>BELLANDE, EMMANUEL ; COMAZZI, VERONIQUE ; LAINE, JACQUES ; PASQUALINI, ROBERTO</creator><creatorcontrib>BELLANDE, EMMANUEL ; COMAZZI, VERONIQUE ; LAINE, JACQUES ; PASQUALINI, ROBERTO</creatorcontrib><description>PCT No. PCT/FR96/01103 Sec. 371 Date Jan. 16, 1998 Sec. 102(e) Date Jan. 16, 1998 PCT Filed Jul. 16, 1996 PCT Pub. No. WO97/03705 PCT Pub. Date Feb. 6, 1997The present invention relates to cardiac tropism radiopharmaceutical products incorporating a nitride complex os a transition metal and having a rapid myocardial clearance. These complexes are based on the formula:(M 3BOND N)L1L2 (I)in which M is a transition metal such as 99mTc and L1 and L2 comply with the formula: in which at least one of the R and R' represents a branched alkyl group having one or more ether functions, a tetrahydrofurfuryl or ether group, a tetrahydrofurfuryl or dioxaspiro or dialkoxy piperidino groups.</description><edition>7</edition><language>ger</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2002</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20020515&amp;DB=EPODOC&amp;CC=AT&amp;NR=E216267T1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25569,76552</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20020515&amp;DB=EPODOC&amp;CC=AT&amp;NR=E216267T1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BELLANDE, EMMANUEL</creatorcontrib><creatorcontrib>COMAZZI, VERONIQUE</creatorcontrib><creatorcontrib>LAINE, JACQUES</creatorcontrib><creatorcontrib>PASQUALINI, ROBERTO</creatorcontrib><title>CARDIOTROPISCHE RADIOPHARMAZEUTIKA,DIE EINEN ÜBERGANGSMETALL-NITRID-KOMPLEX ENTHALTEN UND DIE EINE RASCHE MYOCARDIAL-ELIMINIERUNG AUFWEISEN</title><description>PCT No. PCT/FR96/01103 Sec. 371 Date Jan. 16, 1998 Sec. 102(e) Date Jan. 16, 1998 PCT Filed Jul. 16, 1996 PCT Pub. No. WO97/03705 PCT Pub. Date Feb. 6, 1997The present invention relates to cardiac tropism radiopharmaceutical products incorporating a nitride complex os a transition metal and having a rapid myocardial clearance. These complexes are based on the formula:(M 3BOND N)L1L2 (I)in which M is a transition metal such as 99mTc and L1 and L2 comply with the formula: in which at least one of the R and R' represents a branched alkyl group having one or more ether functions, a tetrahydrofurfuryl or ether group, a tetrahydrofurfuryl or dioxaspiro or dialkoxy piperidino groups.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2002</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjT0OgkAQhWksjHqHtZcCTLQeYYAJuwNZhvjTEGLWyigJHsMjeBsvJiHaW7285Hvfm3rPCGxMhdiipCrKUFkYapmBNXDCWiiHVUyokBhZvV87tClwWhkU0NpnEkuxnxem1HhQyJKBloGsOVa_3eAc1eZYjG-gfdRkiAltzamCOtkjVchzb3Jpr71bfHPmLROUKPNdd29c37Vnd3OPBgTDYBNutiLB-h_mA2TTQXk</recordid><startdate>20020515</startdate><enddate>20020515</enddate><creator>BELLANDE, EMMANUEL</creator><creator>COMAZZI, VERONIQUE</creator><creator>LAINE, JACQUES</creator><creator>PASQUALINI, ROBERTO</creator><scope>EVB</scope></search><sort><creationdate>20020515</creationdate><title>CARDIOTROPISCHE RADIOPHARMAZEUTIKA,DIE EINEN ÜBERGANGSMETALL-NITRID-KOMPLEX ENTHALTEN UND DIE EINE RASCHE MYOCARDIAL-ELIMINIERUNG AUFWEISEN</title><author>BELLANDE, EMMANUEL ; COMAZZI, VERONIQUE ; LAINE, JACQUES ; PASQUALINI, ROBERTO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ATE216267TT13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>ger</language><creationdate>2002</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>BELLANDE, EMMANUEL</creatorcontrib><creatorcontrib>COMAZZI, VERONIQUE</creatorcontrib><creatorcontrib>LAINE, JACQUES</creatorcontrib><creatorcontrib>PASQUALINI, ROBERTO</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BELLANDE, EMMANUEL</au><au>COMAZZI, VERONIQUE</au><au>LAINE, JACQUES</au><au>PASQUALINI, ROBERTO</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>CARDIOTROPISCHE RADIOPHARMAZEUTIKA,DIE EINEN ÜBERGANGSMETALL-NITRID-KOMPLEX ENTHALTEN UND DIE EINE RASCHE MYOCARDIAL-ELIMINIERUNG AUFWEISEN</title><date>2002-05-15</date><risdate>2002</risdate><abstract>PCT No. PCT/FR96/01103 Sec. 371 Date Jan. 16, 1998 Sec. 102(e) Date Jan. 16, 1998 PCT Filed Jul. 16, 1996 PCT Pub. No. WO97/03705 PCT Pub. Date Feb. 6, 1997The present invention relates to cardiac tropism radiopharmaceutical products incorporating a nitride complex os a transition metal and having a rapid myocardial clearance. These complexes are based on the formula:(M 3BOND N)L1L2 (I)in which M is a transition metal such as 99mTc and L1 and L2 comply with the formula: in which at least one of the R and R' represents a branched alkyl group having one or more ether functions, a tetrahydrofurfuryl or ether group, a tetrahydrofurfuryl or dioxaspiro or dialkoxy piperidino groups.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language ger
recordid cdi_epo_espacenet_ATE216267TT1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title CARDIOTROPISCHE RADIOPHARMAZEUTIKA,DIE EINEN ÜBERGANGSMETALL-NITRID-KOMPLEX ENTHALTEN UND DIE EINE RASCHE MYOCARDIAL-ELIMINIERUNG AUFWEISEN
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-16T00%3A28%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BELLANDE,%20EMMANUEL&rft.date=2002-05-15&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EATE216267TT1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true